Cytoskeleton
Network of filamentous proteins that forms the internal framework of cells
Follow Cytoskeleton on Notably News to receive short updates to your email — rarely!
We include updates on Parkinson's disease, ALS, Marfan syndrome, Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Keratin, Charcot–Marie–Tooth disease, Long QT syndrome, Microtubule, Usher syndrome, Spinocerebellar ataxia, Hereditary spherocytosis, Primary ciliary dyskinesia, Tauopathy, Alexander disease, Wiskott–Aldrich syndrome ... and more.
| April 2022 |
Hypertrophic cardiomyopathy
Mavacamten was approved for medical use in the United States as a cardiac myosin inhibitor to reduce left ventricular outflow tract gradient and improve symptoms in patients with obstructive hypertrophic cardiomyopathy.
|
This contents of the box above is based on material from the Wikipedia article Hypertrophic cardiomyopathy, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.